DNA损伤
癌症研究
基诺美
卵巢癌
生物
核蛋白
调节器
核定位序列
DNA修复
核运输
核出口信号
细胞生物学
癌症
机制(生物学)
核DNA
信号转导
激酶
RNA干扰
支票1
PARP1
细胞核
合成致死
染色质重塑
MAPK/ERK通路
肌动蛋白
癌细胞
蛋白激酶A
作者
Xiaoxia Xing,Zhihao Zhang,Longxia Li,Zhouying Shen,Buri Xi,Yixuan Yang,Min Diao,Li Ye,Junxiu Chen,Guanglei Zhuang,Xiaoming Zhou,Ahmed A. Ahmed,Hai Gong,Rongyu Zang,Yiyan Zheng
标识
DOI:10.1073/pnas.2615905123
摘要
Nuclear F-actin facilitates DNA damage repair and contributes to cancer chemoresistance. However, the regulatory mechanisms controlling its dynamic polymerization in response to genotoxic stress remain poorly defined. A major barrier in nuclear actin research is the lack of tools for precise, high-throughput analysis. To systematically investigate nuclear F-actin assembly in DNA damage response, we developed a deep learning pipeline, named nFANet, for high-throughput detection and analysis of nuclear F-actin. Here, using ovarian cancer-a malignancy where chemoresistance is a major clinical obstacle-as a model, we showed that platinum-based chemotherapy robustly induces nuclear F-actin assembly. A subsequent kinome screening, in combination with the application of nFANet, identified the kinase p38α MAPK as a critical upstream regulator of platinum-induced nuclear F-actin assembly. Mechanistically, the p38α MAPK-MK2 signaling pathway promotes formin-mediated nuclear F-actin assembly in response to chemotherapy. Importantly, pharmacological inhibition or genetic knockout of the p38α MAPK-MK2 pathway sensitized ovarian cancer cells to platinum-based therapy. Our work uncovers a key mechanism governing nuclear actin remodeling under genotoxic stress and lays the foundation for identifying a patient subgroup likely to benefit from therapeutic targeting of this pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI